• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CareDx, Inc. - Common Stock (NQ:CDNA)

    19.41 +0.56 (+2.97%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 4, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,081,645
    Open 18.81
    Bid (Size) 19.14 (500)
    Ask (Size) 19.84 (100)
    Prev. Close 18.85
    Today's Range 18.63 - 19.80
    52wk Range 10.96 - 26.37
    Shares Outstanding 52,627,165
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx to Participate in Upcoming Investor Conferences
    From CareDx, Inc.
    Via Business Wire

    Performance

    YTD
    -9.8%
    -9.8%
    1 Month
    +33.7%
    +33.7%
    3 Month
    +48.2%
    +48.2%
    6 Month
    +3.5%
    +3.5%
    1 Year
    -25.1%
    -25.1%

    More News

    Read More
    News headline image
    CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From CareDx, Inc.
    Via Business Wire
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    4 Analysts Assess CareDx: What You Need To Know ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 6, 2025 ↗
    Via Benzinga
    News headline image
    CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
    From CareDx, Inc.
    Via Business Wire
    News headline image
    3 Analysts Have This To Say About CareDx ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    CareDx Announces Third Quarter 2025 Financial Results
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx Issues Comment Letter on Draft LCD Policy
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential ↗
    Via Benzinga
    News headline image
    This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday ↗
    Via Benzinga
    News headline image
    CareDx to Participate in Wells Fargo Healthcare Conference
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx (CDNA) EPS Beats Sales Gain 14% ↗
    Via The Motley Fool
    News headline image
    CareDx Inc (NASDAQ:CDNA) Posts Mixed Q2 2025 Results Amid Revenue Adjustments and Testing Growth ↗
    Via Chartmill
    News headline image
    CareDx Announces Appointment of Nathan Smith as Chief Financial Officer
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx Announces Second Quarter 2025 Financial Results
    From CareDx, Inc.
    Via Business Wire
    News headline image
    CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation
    From CareDx, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is CareDx, Inc. - Common Stock publicly traded?
    Yes, CareDx, Inc. - Common Stock is publicly traded.
    What exchange does CareDx, Inc. - Common Stock trade on?
    CareDx, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for CareDx, Inc. - Common Stock?
    The ticker symbol for CareDx, Inc. - Common Stock is CDNA on the Nasdaq Stock Market
    What is the current price of CareDx, Inc. - Common Stock?
    The current price of CareDx, Inc. - Common Stock is 19.41
    When was CareDx, Inc. - Common Stock last traded?
    The last trade of CareDx, Inc. - Common Stock was at 12/04/25 04:00 PM ET
    What is the market capitalization of CareDx, Inc. - Common Stock?
    The market capitalization of CareDx, Inc. - Common Stock is 1.02B
    How many shares of CareDx, Inc. - Common Stock are outstanding?
    CareDx, Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.